OncoMatch/Clinical Trials/NCT05618821
Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node Dissection for Remnant Gastric Cancer
Is NCT05618821 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2 trial studies Indocyanine Green Tracer for gastric cancer.
Treatment: Indocyanine Green Tracer — Patients with resectable remnant gastric cancer were selected as study subjects to investigate the safety, efficacy, and feasibility of ICG near-infrared imaging tracing in guiding laparoscopic lymph node dissection for remnant gastric cancer by comparing injection ICG group and non-injection ICG group.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Gastric Cancer
Disease stage
Required: Stage N- (AJCC Seventh Edition)
Excluded: Stage DISTANT METASTASIS
cT1-4a, N-/+, M0 at preoperative evaluation according to the American Joint Committee on Cancer (AJCC) Cancer Staging Manual Seventh Edition
Performance status
ECOG 0–1(Restricted strenuous activity)
Demographics
Prior therapy
Cannot have received: neoadjuvant chemotherapy
History of previous neoadjuvant chemotherapy
Cannot have received: radiotherapy
History of previous neoadjuvant...radiotherapy
Lab requirements
Cardiac function
ASA class I to III; FEV1<50% of the predicted values excluded; history of unstable angina or myocardial infarction within past six months excluded
ASA (American Society of Anesthesiology) class I to III; FEV1<50% of the predicted values; History of unstable angina or myocardial infarction within the past six months
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT05618821 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior neoadjuvant chemotherapy, radiotherapy disqualifies patients from enrollment.
What disease stage is eligible?
Stage N- is required.
Is there an age limit?
Yes. Patients must be 75 years or younger.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages